中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2015年
30期
2469-2473
,共5页
杨晓勇%姚庆春%胡小鹏%王玮%尹航%任亮%刘航%张小东
楊曉勇%姚慶春%鬍小鵬%王瑋%尹航%任亮%劉航%張小東
양효용%요경춘%호소붕%왕위%윤항%임량%류항%장소동
雷帕霉素%致耐受性树突细胞%调节性T细胞%移植耐受%Th17细胞
雷帕黴素%緻耐受性樹突細胞%調節性T細胞%移植耐受%Th17細胞
뢰파매소%치내수성수돌세포%조절성T세포%이식내수%Th17세포
Rapamycin%Tolerogenic dendritic cells%Regulatory T cells%Immune tolerance%Th17 cells
目的 应用雷帕霉素体外预处理小鼠树突细胞(DC),制备耐受树突细胞(Tol-DC),并建立同种异基因小鼠皮肤移植模型,Tol-DC过继性输注到小鼠体内,观察移植皮片存活时间及Treg/Th17细胞表达,探讨其诱导移植免疫耐受的可能机制.方法 在小鼠骨髓来源的DC前体培养过程中加入粒细胞-巨噬细胞集落刺激因子(GM-CSF),白细胞介素4(IL-4)和雷帕霉素,用流式细胞仪检测各组DC表面CD11c、CD40和CD80的表达;MTT比色法行体外混合淋巴细胞反应(MLR)观察每组对同种T细胞的刺激增殖能力;同时建立皮肤移植模型,观察皮肤移植前7d经尾静脉注射Tol-DC的受者移植物存活情况;第9天取其脾脏,检测Treg/Th17细胞变化,取移植皮肤HE染色观察炎性细胞的浸润情况.结果 Tol-DC组显著抑制了外源刺激下DC的成熟过程和表面共刺激分子(CD40、CD80)的表达,并显著抑制其同种T细胞激活能力(P<0.01);而且Treg比例升高,Th17下降,小鼠皮肤存活时间延长,炎症反应减轻.结论 应用雷帕霉素能够制备耐受性树突细胞,并诱导小鼠移植免疫耐受,这种作用是通过扩增Treg细胞,抑制Th17细胞而实现的,从而为在临床应用Tol-DC诱导供者特异性免疫耐受提供新的策略.
目的 應用雷帕黴素體外預處理小鼠樹突細胞(DC),製備耐受樹突細胞(Tol-DC),併建立同種異基因小鼠皮膚移植模型,Tol-DC過繼性輸註到小鼠體內,觀察移植皮片存活時間及Treg/Th17細胞錶達,探討其誘導移植免疫耐受的可能機製.方法 在小鼠骨髓來源的DC前體培養過程中加入粒細胞-巨噬細胞集落刺激因子(GM-CSF),白細胞介素4(IL-4)和雷帕黴素,用流式細胞儀檢測各組DC錶麵CD11c、CD40和CD80的錶達;MTT比色法行體外混閤淋巴細胞反應(MLR)觀察每組對同種T細胞的刺激增殖能力;同時建立皮膚移植模型,觀察皮膚移植前7d經尾靜脈註射Tol-DC的受者移植物存活情況;第9天取其脾髒,檢測Treg/Th17細胞變化,取移植皮膚HE染色觀察炎性細胞的浸潤情況.結果 Tol-DC組顯著抑製瞭外源刺激下DC的成熟過程和錶麵共刺激分子(CD40、CD80)的錶達,併顯著抑製其同種T細胞激活能力(P<0.01);而且Treg比例升高,Th17下降,小鼠皮膚存活時間延長,炎癥反應減輕.結論 應用雷帕黴素能夠製備耐受性樹突細胞,併誘導小鼠移植免疫耐受,這種作用是通過擴增Treg細胞,抑製Th17細胞而實現的,從而為在臨床應用Tol-DC誘導供者特異性免疫耐受提供新的策略.
목적 응용뢰파매소체외예처리소서수돌세포(DC),제비내수수돌세포(Tol-DC),병건립동충이기인소서피부이식모형,Tol-DC과계성수주도소서체내,관찰이식피편존활시간급Treg/Th17세포표체,탐토기유도이식면역내수적가능궤제.방법 재소서골수래원적DC전체배양과정중가입립세포-거서세포집락자격인자(GM-CSF),백세포개소4(IL-4)화뢰파매소,용류식세포의검측각조DC표면CD11c、CD40화CD80적표체;MTT비색법행체외혼합림파세포반응(MLR)관찰매조대동충T세포적자격증식능력;동시건립피부이식모형,관찰피부이식전7d경미정맥주사Tol-DC적수자이식물존활정황;제9천취기비장,검측Treg/Th17세포변화,취이식피부HE염색관찰염성세포적침윤정황.결과 Tol-DC조현저억제료외원자격하DC적성숙과정화표면공자격분자(CD40、CD80)적표체,병현저억제기동충T세포격활능력(P<0.01);이차Treg비례승고,Th17하강,소서피부존활시간연장,염증반응감경.결론 응용뢰파매소능구제비내수성수돌세포,병유도소서이식면역내수,저충작용시통과확증Treg세포,억제Th17세포이실현적,종이위재림상응용Tol-DC유도공자특이성면역내수제공신적책략.
Objective To investigate the effect of tolerogenic dendritic cells (Tol-DC) generated by Rapamycin (Rapa) on the differentiation of Treg/Thl7 cells and explore the possible mechanism of tolerance induction.Methods DC progenitors from mouse bone marrow were propagated with granulocyte-macrophage colony-stimulating factor (GM-CSF) plus interleukin (IL)-4 stimulation for 6 days in the presence or absence of Rapa (20 ng/ml).During DC culture,morphology of cell was observed under electron microscope.Cell surface expression of CD11c,CD40 and CD80 was analyzed by flow cytometry.The antigen-presenting function of DC was determined by one-way mixed leukocyte reactions.In vivo,the recipient BALB/c mice receiving transplantation of skin allograft from C57BL/6 mice were divided into control,Rapa,immature DC (imDC) and Tol-DC group.The survival time of the skin allograft was observed and Treg/Th17 cells were analyzed by flow cytometry in each group.Results The immunephenotypic analysis showed that in comparison with those in the control group and the LPS group the expression of the co-stimulatory molecules CD40 and CD80 were significantly lower in the Rapa-group and Rapa + LPS group.The ability to stimulate proliferation of T cells of the same genotype in the Rapa-group was significantly inhibited (P < 0.01).In the in vivo experiment,the mice' s survival time remarkably prolonged,the percentage of Treg cells was enhanced and Th17 cells was reduced in the mice's spleen in Tol-DC group.Conclusions Tol-DC generated by Rapamycin can significantly induce immune tolerance through up-regulate Tregs and down-regulate Th17 cells.The present study highlights the therapeutic potential of preventing allograft rejection using in vitro-generated Tol-DCs,which can be loaded with donor antigen,and potentially used to promote organ transplant tolerance.